Regenerative medicine has experienced a paradigm shift with the advent of platelet‐rich fibrin (PRF) and its integration with growth factors. PRF, an autologous concentrate derived from blood, ...
TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ...
TEL AVIV, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) -- PainReform (PRFX) Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback